Abiraterone acetate

About

Therapy type: Hormone therapy

Therapy strategy: Antiandrogen

Mappings

NCI Thesaurus: Abiraterone Acetate (ncit:C68845)

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) BARD1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisone
Sensitivity (+) BRIP1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisone
Sensitivity (+) BRIP1 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisone
Sensitivity (+) CDK12 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisone
Sensitivity (+) BRCA1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisolone
Sensitivity (+) BRCA1 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisolone
Sensitivity (+) BRCA2 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisolone
Sensitivity (+) BRCA2 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisolone
Sensitivity (+) BRCA1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisone
Sensitivity (+) BRCA1 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisone
Sensitivity (+) BRCA2 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisone
Sensitivity (+) BRCA2 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisone
Sensitivity (+) BRCA1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisolone
Sensitivity (+) BRCA2 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisolone
Sensitivity (+) BRCA1 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisolone
Sensitivity (+) BRCA2 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisolone
Sensitivity (+) BRCA1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisolone
Sensitivity (+) BRCA2 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisolone
Sensitivity (+) BRCA1 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisolone